Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2156964930;64931;64932 chr2:178584936;178584935;178584934chr2:179449663;179449662;179449661
N2AB1992860007;60008;60009 chr2:178584936;178584935;178584934chr2:179449663;179449662;179449661
N2A1900157226;57227;57228 chr2:178584936;178584935;178584934chr2:179449663;179449662;179449661
N2B1250437735;37736;37737 chr2:178584936;178584935;178584934chr2:179449663;179449662;179449661
Novex-11262938110;38111;38112 chr2:178584936;178584935;178584934chr2:179449663;179449662;179449661
Novex-21269638311;38312;38313 chr2:178584936;178584935;178584934chr2:179449663;179449662;179449661
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Fn3-44
  • Domain position: 11
  • Structural Position: 12
  • Q(SASA): 0.8027
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V None None 0.4 N 0.235 0.071 0.446111551642 gnomAD-4.0.0 1.59246E-06 None None None None I None 0 0 None 0 0 None 0 0 0 1.43336E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.7442 likely_pathogenic 0.7405 pathogenic -2.302 Highly Destabilizing 0.985 D 0.58 neutral None None None None I
I/C 0.8338 likely_pathogenic 0.8113 pathogenic -1.773 Destabilizing 1.0 D 0.666 neutral None None None None I
I/D 0.9727 likely_pathogenic 0.9773 pathogenic -1.597 Destabilizing 0.999 D 0.734 prob.delet. None None None None I
I/E 0.9516 likely_pathogenic 0.9586 pathogenic -1.462 Destabilizing 0.999 D 0.736 prob.delet. None None None None I
I/F 0.2379 likely_benign 0.2305 benign -1.495 Destabilizing 0.265 N 0.401 neutral N 0.452197882 None None I
I/G 0.9472 likely_pathogenic 0.9462 pathogenic -2.778 Highly Destabilizing 0.999 D 0.709 prob.delet. None None None None I
I/H 0.8993 likely_pathogenic 0.9115 pathogenic -2.03 Highly Destabilizing 1.0 D 0.71 prob.delet. None None None None I
I/K 0.8773 likely_pathogenic 0.8999 pathogenic -1.588 Destabilizing 0.999 D 0.737 prob.delet. None None None None I
I/L 0.1896 likely_benign 0.1748 benign -0.985 Destabilizing 0.817 D 0.452 neutral N 0.468879488 None None I
I/M 0.1981 likely_benign 0.1988 benign -0.945 Destabilizing 0.997 D 0.599 neutral N 0.485829416 None None I
I/N 0.7846 likely_pathogenic 0.7983 pathogenic -1.618 Destabilizing 0.999 D 0.734 prob.delet. N 0.50946708 None None I
I/P 0.9384 likely_pathogenic 0.9423 pathogenic -1.398 Destabilizing 0.999 D 0.736 prob.delet. None None None None I
I/Q 0.8979 likely_pathogenic 0.9121 pathogenic -1.604 Destabilizing 0.999 D 0.736 prob.delet. None None None None I
I/R 0.8145 likely_pathogenic 0.8441 pathogenic -1.21 Destabilizing 0.999 D 0.739 prob.delet. None None None None I
I/S 0.7792 likely_pathogenic 0.7921 pathogenic -2.447 Highly Destabilizing 0.997 D 0.676 prob.neutral N 0.483854407 None None I
I/T 0.6672 likely_pathogenic 0.687 pathogenic -2.16 Highly Destabilizing 0.98 D 0.609 neutral N 0.47949954 None None I
I/V 0.105 likely_benign 0.099 benign -1.398 Destabilizing 0.4 N 0.235 neutral N 0.457774273 None None I
I/W 0.9296 likely_pathogenic 0.9298 pathogenic -1.639 Destabilizing 1.0 D 0.732 prob.delet. None None None None I
I/Y 0.7658 likely_pathogenic 0.7673 pathogenic -1.402 Destabilizing 0.991 D 0.653 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.